Charles Conway

Professor of Psychiatry

Additional Titles & Roles

  • Director, Treatment Resistant Depression and Neurostimulation Clinic
  • Director, Washington University Center for the Advancement of Research in Resistant Mood and Affective Disorders (CARRMA)
  • Interventional Psychiatry Rotation Director

Education & Training

  • Residency: Duke University, Durham, NC, 1999
  • MD: University of Missouri, Columbia, MO, 1995
  • BA: Biology: St. Louis University, St. Louis, MO, 1987

Major Awards

  • Ziskind-Somerfeld Research Award, Society of Biological Psychiatry, 2016
  • Best Doctors in America, (Best Doctors, Inc.), 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019
  • Resident Faculty Teaching Award, Washington University, 2014
  • Resident Mentor Award, Washington University, 2011
  • NARSAD Sidney Baer Award, 2007
  • Resident Faculty Teaching Award, St. Louis University, 2004, 2007

Areas of Clinical Interest

mood disorders, treatment-resistant mood disorders, bipolar disorders

Research Interests

treatment-resistant depression (TRD) phenomenology, novel treatments for TRD, neuroimaging of mood disorders, bipolar disorders

Key Publications

Funded Research Projects

American Foundation of Suicide Prevention (Co-PI). Adjunctive Nitrous Oxide for Acute Suicidal Ideation in Unipolar Depressed Hospitalized Patients.

Assurex Health (PI). Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder (MDD).

Brain and Behavior Research Foundation (Co-I). Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies.

NIMH R21 (Co-PI). Targeting Affective Circuits Using the N-methyl-D-Aspartate (NMDA) Antagonist Nitrous Oxide.

Taylor Family Institute for Innovative Psychiatric Research (PI): Biological and Psychological Phenomenology Studies of Treatment-Resistant Depressive Disorder.